|
|
||||||||


* Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University, Mainz, Germany; and
Department of Microbiology and Immunology, University of Leicester, Leicester, United Kingdom
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
MBL is a member of the collectin family, a protein family characterized by an N-terminal, collagen-like domain and a C-terminal, C-type carbohydrate recognition domain. In contrast to C1q, the collagen-like recognition molecule of the classical complement pathway, which is a hetero-oligomer, MBL, like all other members of the collectin family, is a homo-oligomer.
At the genomic level, MBL has been characterized in many species and has been found in serum in two forms (MBL-A and MBL-C) in rodents, rabbits, and rhesus monkeys, but only in one form in humans and chimpanzees (5). The two murine MBL genes probably arose through gene duplication before human-rodent divergence (6).
In BALB/c mice the serum concentrations of MBL-A and MBL-C were 9.4 and 29 µg/µl, respectively (7). Both types of MBL trigger Ab-independent activation of the complement system (8). Whether they have other common or divergent biological functions is not yet known.
To date, only hepatocytes have been shown to synthesize MBL, except for the rat, in which extrahepatic expression of MBL-A protein has been reported in the kidney (9, 10, 11).
| Materials and Methods |
|---|
|
|
|---|
BALB/c mice were originally purchased from Charles River Laboratories (Sulzfeld, Germany) and then were maintained and bred under standard conditions in the animal unit of our institute.
Antibodies
Antisera against murine MBL-A and MBL-C were generated by immunizing New Zealand White rabbits (Charles River, Sulzfeld, Germany) twice with 150 µg of purified recombinant murine MBL-A or MBL-C expressed by insect cells (S. Wagner, S. Thiel, F. Petry, and M. Loos, manuscript in preparation). The immunizations were performed in the presence of Ribi Adjuvant (Universal Biologicals, Stroud, U.K.). The specificity of the polyclonal Abs was verified in a Western blot analysis of purified recombinant MBL-A and MBL-C produced in insect cells and by comparison of the staining pattern with that obtained with recently described anti-MBL-A and MBL-C mAbs (7).
Complementary DNA synthesis
A pool of total RNA was prepared from freshly isolated tissues from six female and four male mice, according to the method of Chomczynski and Sacchi (12). One hundred nanograms of each sample was primed with oligo(dT)1218, and single-stranded cDNAs were synthesized using the Superscript First-Strand kit (Invitrogen, Paisley, U.K.) according to the suppliers instructions.
The integrity of each cDNA sample was checked by PCR using
-actin-specific primers (sense, 5'-TGGAATCCTGTGGCATCCAGTAAAC-3'; antisense, 5'-GTGCCAGGCTCTTGGCTCC-3'). The RT-PCR amplification profile consisted of an initial denaturation step at 94°C for 5 min, followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, 72°C for 1 min, and a final extension for 5 min at 72°C.
Quantitative real-time RT-PCR
Quantitative PCR was performed in a LightCycler instrument (Roche Diagnostics, Mannheim, Germany), using the FastStart DNA Master SYBR Green I kit (also from Roche), and results were analyzed using the LDCA software supplied with the machine (13). A 295-bp fragment of MBL-A was amplified using primers MBL-A-F1 (5'-CAG GGT CAC AAA CCT GTG AG-3') and MBL-A-R1 (5'-TGC AAC TTG TTG GTT AGC TG-3'). A 305-bp fragment of MBL-C was amplified using primers mC-F1 (5'-GAC CTT AAC CGA AGG TGT TCA-3') and mC-R1 (5'-CAG TTT CTC AGG GCT CTC AG-3'). Each 20-µl PCR contained 1/80th of the original cDNA synthesis reaction (corresponding to 1.25 ng of total RNA), 3.5 mM MgCl2, 0.5 µM of each primer, and 2 µl of the master mix supplied with the kit. Forty-five cycles of amplification were performed: the annealing temperature was reduced from 70 to 58°C during the first 15 cycles and was held constant at 58°C thereafter. The fluorescence signal was detected at the end of each cycle. Melting curve analysis was used to confirm the specificity of the products (14). A standard curve was produced for each form of MBL using serial dilutions of the corresponding cDNAs cloned into pIZ/V5-His (Invitrogen) as templates for the reaction.
In situ hybridization
MBL-A and MBL-C mRNAs were localized by in situ hybridization using 35S-labeled antisense RNA probes. In vitro transcription and in situ hybridization were performed according to the methods of Melton et al. (15) and Schäfer et al. (16), respectively. The template for the production of the MBL-A probe was a 406-bp fragment of cDNA, stretching from an internal BamHI site to the 3' end of the cDNA, which was cloned into pBSIIKS+. The MBL-C probe was transcribed from a cDNA template comprising the 264 bp between two internal EcoRI sites, subcloned probe pBSIIKS+. To generate specific cRNA probes in antisense orientation, the template was linearized by XbaI digestion, and cRNA was transcribed using T7 RNA polymerase. To control the specificity of hybridization, cRNA probes were transcribed also in sense orientation, linearizing the MBL-A and MBL-C templates by XhoI digestion for in vitro transcription using T3 RNA polymerase.
Twenty-micrometer-thick sections of mouse tissue were cut using a cryostat, mounted on polylysine-coated microscope slides (Merck, Poole, U.K.), and hybridized with the 35S-labeled probes. After hybridization and washing, the signals were detected by exposing the sections to Kodak BioMax MR x-ray film (Sigma-Aldrich, Poole, U.K.) or by dipping the slides in LM-1 photographic emulsion (Amersham Pharmacia Biotech, Uppsala, Sweden).
Immunohistochemistry
To locate MBL-A and MBL-C protein expression in different organs by immunohistochemistry the following procedure was performed. Sections (5 µm) were cut and mounted as described above. Sections were then fixed in PBS/4% paraformaldehyde and permeabilized with PBS/0.06% Triton X-100. To avoid nonspecific staining the samples were incubated with PBS/1% H2O2, then blocked with a biotin-blocking system (DAKO, Hamburg, Germany). The sections were incubated with polyclonal rabbit anti-mouse MBL-A or MBL-C Abs (IgG fraction, diluted 1/15). Alternatively, irrelevant rabbit IgG in the same dilution were used for negative controls. All following steps were conducted according to the manufacturers instructions with the rabbit ABC staining system (Santa Cruz Biotechnology, Santa Cruz, CA). Immunostained sections were counterstained in hematoxylin, analyzed, and photographed with the Zeiss Axioskop 2 and the digital Axiocam HRc (Zeiss, Gottingen, Germany).
| Results |
|---|
|
|
|---|
The concentrations of MBL-A and MBL-C mRNAs in various mouse tissues were determined by quantitative RT-PCR, using a Roche LightCycler to follow the incorporation of SYBR Green I into the PCR products in real time. A standard curve was prepared for each of the two forms of MBL cDNA using serial dilutions of a plasmid containing the appropriate cDNA as templates for the PCR (Fig. 1A).
|
In situ hybridization and immunohistochemistry
In situ hybridization was used to localize MBL mRNAs in whole body sections of newborn mice and in sections of adult mouse liver, small intestine, and spleen. Macroscopic examination of the newborn mouse sections and sections of liver from adult mice confirmed that the liver is the principal site of expression for both types of MBL (Fig. 2, AF), while microscopic examination of liver sections dipped in photo emulsion showed that essentially all hepatocytes express both types of MBL (data not shown). MBL-C expression, but not MBL-A expression, was seen in the small intestine (Fig. 2, G and H). In the spleen a weak, diffuse expression of both MBL mRNAs could be detected throughout the red pulp and in the peripheral macrophage zone (data not shown). The sections were also hybridized with riboprobes transcribed in the sense orientation from MBL-A and MBL-C cDNAs. Within MBL-C sense controls no detectable signals were observed (data not shown).
|
|
| Discussion |
|---|
|
|
|---|
Using quantitative real-time PCR, it was found that the liver is indeed the major site of MBL mRNA expression. The level of MBL-C is three times higher than that of MBL-A (69,000 vs 23,000 copies/ng RNA). This ratio is in strikingly close agreement with the ratio of the serum concentrations of MBL-C and MBL-A in BALB/c mice as reported by Liu et al. (7). In situ hybridization and immunohistochemistry, using MBL-A- and MBL-C-specific cRNA probes and Abs, show that essentially all hepatocytes express both forms of the lectin.
Elsewhere, the highest MBL-A mRNA level was found in kidney, 650 copies/ng RNA. This is
30-fold less than that in liver, in contrast to previously published results, which indicate that renal MBL-A levels are about one-eighth of those in liver (11). Immunohistochemistry localized the MBL-A-expressing cells to the cortex of the kidney, in particular to the glomeruli. Very little MBL-C could be detected.
Nonhepatic MBL-C expression was highest in the small intestine, where it may play a role in defense against intestinal micro-organisms. As proposed for the collectin lung surfactant protein D, which was found to be expressed on several mucosal surfaces in humans and mice, MBL-C as part of the innate immune system could be seen as a counterpart of secretory IgA of the acquired immune system (18, 19). Due to its capability to bind to various micro-organisms, MBL-C as well as IgA may protect the small intestine against invading pathogens. In addition, it has been reported that human MBL activates complement after binding to sporozoites of the intestinal parasite Cryptosporidium parvum (20).
In spleen MBL-A and MBL-C mRNA levels were very similar (420 and 450 copies/ng RNA, respectively), and the expression of both types was highest in the marginal macrophage zone. Interestingly, MBL-A and MBL-C were also expressed in the brain (130 and 150 copies/ng RNA, respectively), as is the complement component C1q, which is dramatically up-regulated in response to CNS inflammation (21).
The mRNA levels for MBL-A in testis (57 copies/ng RNA) and muscle (16 copies/ng RNA) and for MBL-C in muscle (15 copies/ng RNA) and kidney (13 copies/ng RNA) are so low that they presumably only play minor roles.
Precisely why rodents have two forms of MBL is not clear. The two lectins have slightly different ligand specificities, which might broaden the spectrum of micro-organisms that they can recognize. However, the finding that MBL-A and MBL-C are differentially expressed together with earlier reports that MBL-A, but not MBL-C, is a mild acute phase protein (7) clearly demonstrate that the two genes are independently regulated and imply distinct biological roles for the two lectins.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Michael Loos, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University Mainz, Augustusplatz/Hochhaus, D-55101 Mainz, Germany. E-mail address: mloos{at}mail.uni-mainz.de ![]()
3 Abbreviations used in this paper: MBL, mannose-binding lectin; MASP, MBL-associated serine protease. ![]()
Received for publication September 11, 2002. Accepted for publication November 20, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Wallis, N. J. Lynch, S. Roscher, K. B. Reid, and W. J. Schwaeble Decoupling of Carbohydrate Binding and MASP-2 Autoactivation in Variant Mannose-Binding Lectins Associated with Immunodeficiency J. Immunol., November 15, 2005; 175(10): 6846 - 6851. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Lynch, S.-u.-H. Khan, C. M. Stover, S. M. Sandrini, D. Marston, J. S. Presanis, and W. J. Schwaeble Composition of the Lectin Pathway of Complement in Gallus gallus: Absence of Mannan-Binding Lectin-Associated Serine Protease-1 in Birds J. Immunol., April 15, 2005; 174(8): 4998 - 5006. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. de Vries, S. J. Walter, C. J. Peutz-Kootstra, T. G.A.M. Wolfs, L.W. E. van Heurn, and W. A. Buurman The Mannose-Binding Lectin-Pathway Is Involved in Complement Activation in the Course of Renal Ischemia-Reperfusion Injury Am. J. Pathol., November 1, 2004; 165(5): 1677 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cattaruzza, T. J. Guzik, W. Slodowski, A. Pelvan, J. Becker, M. Halle, A. B. Buchwald, K. M. Channon, and M. Hecker Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease Circ. Res., October 15, 2004; 95(8): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Windbichler, B. Echtenacher, T. Hehlgans, J. C. Jensenius, W. Schwaeble, and D. N. Mannel Involvement of the Lectin Pathway of Complement Activation in Antimicrobial Immune Defense during Experimental Septic Peritonitis Infect. Immun., September 1, 2004; 72(9): 5247 - 5252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Hogaboam, K. Takahashi, R. A. B. Ezekowitz, S. L. Kunkel, and J. M. Schuh Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile J. Leukoc. Biol., May 1, 2004; 75(5): 805 - 814. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |